The polymorphism in the let-7 targeted region of the Lin28 gene is associated with increased risk of type 2 diabetes mellitus

Molecular and Cellular Endocrinology

Volumn 375, Issue 1-2, 2013, Pages 53-57

  Zhang, Jie ^a   Zhang, Longyi ^a   Fan, Runping ^a   Guo, Nengneng ^a   Xiong, Chunhui ^a   Wang, Lin ^a   Jin, Sheng ^a   Li, Wei ^a   Lu, Jianxin ^a  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

Let 7; Lin28; MiRNAs; Polymorphisms; Type 2 diabetes mellitus

Indexed keywords

LET 7 MICRORNA; MICRORNA; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; HYPERTENSION; LIN28 GENE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SEX DIFFERENCE;

AGED; BINDING SITES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA-BINDING PROTEINS; SEX CHARACTERISTICS; SEX DISTRIBUTION;

EID: 84878680769     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.04.022     Document Type: Article

References (29)

1. Chen A.X., Yu K.D., Fan L., Li J.Y., Yang C., Huang A.J., Shao Z.M. Germline genetic variants disturbing the Let-7/LIN28 double-negative feedback loop alter breast cancer susceptibility. PLoS Genet. 2011, 7:e1002259.
2. Chitwood D.H., Timmermans M.C.P. Small RNAs are on the move. Nature 2010, 467:415-419.
3. Cochrane D.R., Jacobsen B.M., Connaghan K.D., Howe E.N., Bain D.L., Richer J.K. Progestin regulated miRNAs that mediate progesterone receptor action in breast cancer. Mol. Cell Endocrinol. 2012, 315:15-24.
4. El-Khairi R., Parnaik R., Duncan A.J., Lin L., Gerrelli D., Dattani M.T., Conway G.S., Achermann J.C. Analysis of LIN28A in early human ovary development and as a candidate gene for primary ovarian insufficiency. Mol. Cell Endocrinol. 2012, 351:264-268.
5. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
6. Frost R.J.A., Olson E.N. Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc. Natl. Acad. Sci. USA 2011, 108:21075-21080.
7. Furer V., Greenberg J.D., Attur M., Abramson S.B., Pillinger M.H. The role of microRNA in rheumatoid arthritis and other autoimmune diseases. Clin. Immunol. 2010, 136:1-15.
8. Gallagher I.J., Scheele C., Keller P., Nielsen A.R., Remenyi J., Fischer C.P., Roder K., Babraj J., Wahlestedt C., Hutvagner G. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med. 2010, 2.
9. Greco D., Kivi N., Qian K., Leivonen S.K., Auvinen P., Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS ONE 2011, 6:e21646.
10. Guay C., Roggli E., Nesca V., Jacovetti C., Regazzi R. Diabetes mellitus, a microRNA-related disease?. Transl. Res. 2011, 157:253-264.
11. Herrera B.M., Lockstone H.E., Taylor J.M., Ria M., Barrett A., Collins S., Kaisaki P., Argoud K., Fernandez C., Travers M.E. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 2010, 53:1099-1109.
12. Lee J.E., Choi Y.K., Seo H., Jeon J.H., Jeong J.Y., Moon S.S., Kim J.G., Kim B.W., Kim S.W., Yoo M. Impact of ENPP1 and MMP3 gene polymorphisms on aortic calcification in patients with type 2 diabetes in a Korean population. Diabetes Res. Clin. Pr. 2010, 88:87-96.
13. Mishra P.J., Bertino J.R. MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics 2009, 10:399-416.
14. Papazoglou I., Berthou F., Vicaire N., Rouch C., Markaki E.M., Bailbe D., Portha B., Taouis M., Gerozissis K. Hypothalamic serotonin-insulin signaling cross-talk and alterations in a type 2 diabetic model. Mol. Cell Endocrinol. 2011, 350:136-144.
15. Patel C.J., Bhattacharya J., Butte A.J. An environment-wide association study (EWAS) on type 2 diabetes mellitus. PLoS ONE 2010, 5:e10746.
16. Rauseo A., Pacilli A., Palena A., De Cosmo S.A. Management of type 2 diabetes in geriatric patients. J. Nephrol. 2010, 23:S72-S79.
17. Ryan B.M., Robles A.I., Harris C.C. Genetic variation in microRNA networks: the implications for cancer research. Nat. Rev. Cancer 2010, 10:389-402.
18. Saunders M.A., Liang H., Li W.H. Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. USA 2007, 104:3300-3305.
19. Sethupathy P., Collins F.S. MicroRNA target site polymorphisms and human disease. Trends Genet. 2008, 24:489-497.
20. Slaby O., Bienertova Vasku J., Svoboda M., Vyzula R. Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J. Cell Mol. Med. 2012, 16:8-21.
21. Stolerman E.S., Florez J.C. Genomics of type 2 diabetes mellitus: implications for the clinician. Nat. Rev. Endocrinol. 2009, 5:429-436.
22. Stumvoll M., Goldstein B.J., van Haeften T.W. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 2005, 365:1333-1346.
23. Sun C., Liu X., Zhang H., Guo W., Cai Z., Chen H., Zhang K., Zhu D., Wang Y. Functional polymorphism of hOGG1 gene is associated with type 2 diabetes mellitus in Chinese population. Mol. Cell Endocrinol. 2010, 325:128-134.
24. Sun K., Li Y., Wei C., Tong Y., Zheng H., Guo Y. Recessive protective effect of ADIPOQ rs1501299 on cardiovascular diseases with type 2 diabetes: a meta-analysis. Mol. Cell Endocrinol. 2011, 315:162-169.
25. Tahrani A.A., Bailey C.J., Del Prato S., Barnett A.H. Management of type 2 diabetes: new and future developments in treatment. Lancet 2011, 378:182-197.
26. Touskova V., Trachta P., Kavalkova P., Drapalova J., Haluzikova D., Mraz M., Lacinova Z., Marek J., Haluzik M. Serum concentrations and tissue expression of components of insulin-like growth factor-axis in females with type 2 diabetes mellitus and obesity: the influence of very low calorie diet. Mol. Cell Endocrinol. 2012, 361:172-178.
27. Wang G., Van Der Walt J.M., Mayhew G., Li Y.J., Züchner S., Scott W.K., Martin E.R., Vance J.M. Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of α-synuclein. Am. J. Hum. Genet. 2008, 82:283-289.
28. Yue C., Wang M., Ding B., Wang W., Fu S., Zhou D., Zhang Z., Han S. Polymorphism of the pre-miR-146a is associated with risk of cervical cancer in a Chinese population. Gynecol. Oncol. 2011, 122:33-37.
29. Zhu H., Shyh-Chang N., Segrè A.V., Shinoda G., Shah S.P., Einhorn W.S., Takeuchi A., Engreitz J.M., Hagan J.P., Kharas M.G. The Lin28/let-7 axis regulates glucose metabolism. Cell 2011, 147:81-94.